Connect Biopharma is trading at $0.82, down -6.30%, during the October 21 session; no company-specific announcement explaining the decline was found in available search results. - The latest company press release listed was September 30. - The biotech sector was positive, with XBI up 2.10%, so it does not explain the stock’s move in the same direction. - No trading-volume information was available to assess activity.